Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biologics
American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis With Systemic Medications
June 21st, 2009
Based on an extensive review of scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with traditional systemic therapies. Recommendations, efficacy and safety for the use of the three U.S. Food & Drug Administration (FDA) approved and most commonly used traditional systemic agents - methotrexate, cyclosporine and acitretin - were outlined. Published online in the Journal of the American Academy of Dermatology, this is the Academy's fourth of six sections of the guidelines of care for psoriasis, with three...
Source: Medical Letter on the CDC & FDA (2009-06-21)
|
